Chu T - Search Results

1

Synthesis and Bioevaluation of Novel [¹⁸F]FDG-Conjugated 2-Nitroimidazole Derivatives for Tumor Hypoxia Imaging.

Yang X, Wang F, Zhu H, Yang Z, Chu T. Yang X, et al. Among authors: chu t. Mol Pharm. 2019 May 6;16(5):2118-2128. doi: 10.1021/acs.molpharmaceut.9b00075. Epub 2019 Apr 19. Mol Pharm. 2019. PMID: 30964298

2

Synthesis and biological results of the technetium-99m-labeled 4-nitroimidazole for imaging tumor hypoxia.

Chu T, Hu S, Wei B, Wang Y, Liu X, Wang X. Chu T, et al. Bioorg Med Chem Lett. 2004 Feb 9;14(3):747-9. doi: 10.1016/j.bmcl.2003.11.017. Bioorg Med Chem Lett. 2004. PMID: 14741282

3

Preparation and biodistribution of technetium-99m-labeled 1-(2-nitroimidazole-1-yl)-propanhydroxyiminoamide (N2IPA) as a tumor hypoxia marker.

Chu T, Li R, Hu S, Liu X, Wang X. Chu T, et al. Nucl Med Biol. 2004 Feb;31(2):199-203. doi: 10.1016/j.nucmedbio.2003.08.007. Nucl Med Biol. 2004. PMID: 15013485

4

Synthesis and in vitro and in vivo evaluation of three radioiodinated nitroimidazole analogues as tumor hypoxia markers.

Li Z, Chu T, Liu X, Wang X. Li Z, et al. Among authors: chu t. Nucl Med Biol. 2005 Apr;32(3):225-31. doi: 10.1016/j.nucmedbio.2005.01.004. Nucl Med Biol. 2005. PMID: 15820757

5

Synthesis and preliminary biological evaluation of the 99mTc labeled nitrobenzoimidazole and nitrotriazole as tumor hypoxia markers.

Zhang Y, Chu T, Gao X, Liu X, Yang Z, Guo Z, Wang X. Zhang Y, et al. Among authors: chu t. Bioorg Med Chem Lett. 2006 Apr 1;16(7):1831-3. doi: 10.1016/j.bmcl.2006.01.001. Epub 2006 Feb 7. Bioorg Med Chem Lett. 2006. PMID: 16460938

6

Synthesis and in vitro evaluation of three 99mTc-labeled hydroxamamide-based ligands as markers for hypoxic cells.

Chu T, Xu H, Yang Z, Wang X. Chu T, et al. Appl Radiat Isot. 2009 Apr;67(4):590-3. doi: 10.1016/j.apradiso.2008.12.003. Epub 2008 Dec 16. Appl Radiat Isot. 2009. PMID: 19144525

7

Effect of a second nitroimidazole redox centre on the accumulation of a hypoxia marker: synthesis and in vitro evaluation of 99mTc-labeled bisnitroimidazole propylene amine oxime complexes.

Huang H, Zhou H, Li Z, Wang X, Chu T. Huang H, et al. Among authors: chu t. Bioorg Med Chem Lett. 2012 Jan 1;22(1):172-7. doi: 10.1016/j.bmcl.2011.11.042. Epub 2011 Nov 18. Bioorg Med Chem Lett. 2012. PMID: 22153341

8

Recent advances on radionuclide labeled hypoxia-imaging agents.

Li Z, Chu T. Li Z, et al. Among authors: chu t. Curr Pharm Des. 2012;18(8):1084-97. doi: 10.2174/138161212799315849. Curr Pharm Des. 2012. PMID: 22272826 Review.

9

Synthesis, radiolabeling and biological evaluation of propylene amine oxime complexes containing nitrotriazoles as hypoxia markers.

Huang H, Mei L, Chu T. Huang H, et al. Among authors: chu t. Molecules. 2012 Jun 4;17(6):6808-20. doi: 10.3390/molecules17066808. Molecules. 2012. PMID: 22664468 Free PMC article.

10

⁹⁹mTc/Re complexes bearing bisnitroimidazole or mononitroimidazole as potential bioreductive markers for tumor: synthesis, physicochemical characterization and biological evaluation.

Mei L, Wang Y, Chu T. Mei L, et al. Among authors: chu t. Eur J Med Chem. 2012 Dec;58:50-63. doi: 10.1016/j.ejmech.2012.09.042. Epub 2012 Oct 4. Eur J Med Chem. 2012. PMID: 23088932

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,751 results

Search Page

Filters